Submitted by Anonymous (not verified) on 26 November 2025 - 15:00
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zejula, niraparib, Date of authorisation: 16/11/2017, Revision: 28, Status: Authorised